BioNexus Gene Lab Corp [NASDAQ: BGLC] closed the trading session at $0.35.
The stocks have a year to date performance of -33.96 percent and weekly performance of 20.19 percent. The stock has been moved at -20.45 percent over the last six months. The stock has performed -2.78 percent around the most recent 30 days and changed -16.92 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 368.21K shares, BGLC reached to a volume of 25778143 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about BioNexus Gene Lab Corp [BGLC]:
The Average True Range (ATR) for BioNexus Gene Lab Corp is set at 0.04, with the Price to Sales ratio for BGLC stock in the period of the last 12 months amounting to 0.66. The Price to Book ratio for the last quarter was 0.67, with the Price to Cash per share for the same quarter was set at 0.24.
BGLC stock trade performance evaluation
BioNexus Gene Lab Corp [BGLC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.19. With this latest performance, BGLC shares dropped by -2.78% in over the last four-week period, additionally sinking by -20.45% over the last 6 months – not to mention a drop of -63.16% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BGLC stock in for the last two-week period is set at 56.97, with the RSI for the last a single of trading hit 64.30, and the three-weeks RSI is set at 52.43 for BioNexus Gene Lab Corp [BGLC]. The present Moving Average for the last 50 days of trading for this stock 0.3640, while it was recorded at 0.2631 for the last single week of trading, and 0.5088 for the last 200 days.
BioNexus Gene Lab Corp [BGLC]: An insightful look at the core fundamentals
BioNexus Gene Lab Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.99 and a Current Ratio set at 4.98.
